Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Riding High on Potential Cannabis, Nicotine Uses of Patented Technology

  • Lexaria Bioscience is helping to revolutionize efforts to provide common drug substances in an ingestible method that avoids unhealthy practices such as inhaled smoking or vaping
  • Lexaria’s DehydraTECH platform works to deliver the chemical compounds to the blood stream at speeds comparable to inhalation methods, providing the means for discrete use and avoiding frustrating waits for users with dependencies
  • The company recently obtained a patent in Australia that recognizes DehydraTECH not only as a food and beverage platform, but also as a potential means of pharmaceutical use for combatting select illnesses
  • As Canada prepares to introduce legalization of cannabis food and beverage products next month, analysts forecast a market worth $2.7 billion a year for edibles and alternative cannabis products, with extract products including edibles comprising 60 percent of the total

As Canada prepares to roll out its ‘Cannabis 2.0’ wave of product legalization focused on edible and drinkable forms of the plant’s core ingredients less than a month from now, with the products themselves hitting store shelves beginning in December, analysts are anticipating a consumables market rife with opportunity for innovation. Deloitte predicts the Canadian market for edibles and alternative cannabis products alone will be worth $2.7 billion annually, and that cannabis extract-based products including edibles will make up nearly 60 percent of that amount at $1.6 billion (http://cnw.fm/Mh0U0).

Bioactive technology innovator Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) is preparing to make its presence known in this new marketplace, building on a relationship forged with alcohol-free beer, wine and adult format beverage maker Hill Street Beverage Company Inc. (TSX.V: BEER) to present its…

Read More>>

NOTE TO INVESTORS: The latest news and updates relating to LXRP are available in the company’s newsroom at http://cnw.fm/LXRP

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

Leave a Reply